159 related articles for article (PubMed ID: 7918702)
21. GABAA-benzodiazepine receptor availability in smokers and nonsmokers: relationship to subsyndromal anxiety and depression.
Esterlis I; Cosgrove KP; Batis JC; Bois F; Kloczynski TA; Stiklus SM; Perry E; Tamagnan GD; Seibyl JP; Makuch R; Krishnan-Sarin S; O'Malley S; Staley JK
Synapse; 2009 Dec; 63(12):1089-99. PubMed ID: 19642218
[TBL] [Abstract][Full Text] [Related]
22. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study.
Malizia AL; Cunningham VJ; Bell CJ; Liddle PF; Jones T; Nutt DJ
Arch Gen Psychiatry; 1998 Aug; 55(8):715-20. PubMed ID: 9707382
[TBL] [Abstract][Full Text] [Related]
23. Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF.
Ohyama M; Senda M; Ishiwata K; Kitamura S; Mishina M; Ishii K; Toyama H; Oda K; Katayama Y
Ann Nucl Med; 1999 Oct; 13(5):309-15. PubMed ID: 10582800
[TBL] [Abstract][Full Text] [Related]
24. Central benzodiazepine receptor distribution after subcortical hemorrhage evaluated by means of [123I]iomazenil and SPECT.
Hatazawa J; Shimosegawa E; Satoh T; Kanno I; Uemura K
Stroke; 1995 Dec; 26(12):2267-71. PubMed ID: 7491648
[TBL] [Abstract][Full Text] [Related]
25. Benzodiazepine receptor distribution in severe intractable tinnitus.
Daftary A; Shulman A; Strashun AM; Gottschalk C; Zoghbi SS; Seibyl JP
Int Tinnitus J; 2004; 10(1):17-23. PubMed ID: 15379343
[TBL] [Abstract][Full Text] [Related]
26. Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder.
Cameron OG; Huang GC; Nichols T; Koeppe RA; Minoshima S; Rose D; Frey KA
Arch Gen Psychiatry; 2007 Jul; 64(7):793-800. PubMed ID: 17606813
[TBL] [Abstract][Full Text] [Related]
27. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding.
Northoff G; Steinke R; Czcervenka C; Krause R; Ulrich S; Danos P; Kropf D; Otto H; Bogerts B
J Neurol Neurosurg Psychiatry; 1999 Oct; 67(4):445-50. PubMed ID: 10486389
[TBL] [Abstract][Full Text] [Related]
28. Benzodiazepine receptor imaging with iomazenil SPECT in aphasic patients with cerebral infarction.
Koshi Y; Kitamura S; Ohyama M; Komiyama T; Komaba Y; Sakayori O; Mishina M; Ishiwata A; Terashi A; Katayama Y
Ann Nucl Med; 1999 Aug; 13(4):223-9. PubMed ID: 10510877
[TBL] [Abstract][Full Text] [Related]
29. Correct localization of epileptogenic focus with I-123 iomazenil cerebral benzodiazepine receptor imaging: a case report of temporal lobe epilepsy with discordant ictal cerebral blood flow SPECT.
Shuke N; Hashizume K; Kiriyama K; Okizaki A; Yamamoto W; Zhao C; Nakai H; Tanaka T; Aburano T
Ann Nucl Med; 2004 Sep; 18(6):541-5. PubMed ID: 15515757
[TBL] [Abstract][Full Text] [Related]
30. [Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP].
Kitamura S; Koshi Y; Komiyama T; Sakayori O; Komaba Y; Ohyama M; Mishina M; Tsuganesawa T; Terashi A
Kaku Igaku; 1996 Jan; 33(1):49-56. PubMed ID: 8819714
[TBL] [Abstract][Full Text] [Related]
31. Epileptic negative myoclonus: a combined study of EEG and [123I]iomazenil (123I-IMZ) single photon emission computed tomography indicating involvement of medial frontal area.
Usui K; Matsuda K; Terada K; Nikaido K; Matsuhashi M; Nakamura F; Umeoka S; Usui N; Tottori T; Baba K; Inoue Y
Epilepsy Res; 2010 May; 89(2-3):220-6. PubMed ID: 20133106
[TBL] [Abstract][Full Text] [Related]
32. [Phase 1 clinical study of 123I-iomazenil: a new probe to evaluate central-type benzodiazepine receptor with SPECT].
Yonekura Y; Nishizawa S; Tanaka F; Ishizu K; Okazawa H; Fujita T; Konishi J; Torizuka K
Kaku Igaku; 1995 Jan; 32(1):87-97. PubMed ID: 7897872
[TBL] [Abstract][Full Text] [Related]
33. Increased benzodiazepine receptor density in the prefrontal cortex in patients with panic disorder.
Brandt CA; Meller J; Keweloh L; Höschel K; Staedt J; Munz D; Stoppe G
J Neural Transm (Vienna); 1998; 105(10-12):1325-33. PubMed ID: 9928900
[TBL] [Abstract][Full Text] [Related]
34. [In vivo autoradiographic benzodiazepine receptor imaging with 125I-iomazenil (Ro 16-0154)].
Odano I; Nakajima T; Miyashita K; Takahashi N; Fujita M; Naritomi H; Furusawa T; Hayashi S; Sakai K
Kaku Igaku; 1993 Jul; 30(7):761-7. PubMed ID: 8397310
[TBL] [Abstract][Full Text] [Related]
35. 123I-iomazenil: a quantitative study of the central benzodiazepine receptor distribution.
Haldemann RC; Bicik I; Pfeiffer A; Wieser HG; Hasler PH; Schubiger P; von Schulthess GK
Nuklearmedizin; 1992 Jun; 31(3):91-7. PubMed ID: 1322533
[TBL] [Abstract][Full Text] [Related]
36. Assessment of benzodiazepine receptors using iodine-123-labeled iomazenil single-photon emission computed tomography in patients with ischemic cerebrovascular disease. A comparison with PET study.
Dong Y; Fukuyama H; Nabatame H; Yamauchi H; Shibasaki H; Yonekura Y
Stroke; 1997 Sep; 28(9):1776-82. PubMed ID: 9303025
[TBL] [Abstract][Full Text] [Related]
37. Quantification of central benzodiazepine receptor binding potential in the brain with 123I-iomazenil SPECT: technical and interobserver variability.
Verhoeff NP; Erbas B; Kapucu O; Busemann Sokole E; Blok H; Van Royen EA
Nucl Med Commun; 1993 Aug; 14(8):634-43. PubMed ID: 8396758
[TBL] [Abstract][Full Text] [Related]
38. Benzodiazepine receptor quantification in Huntington's disease with [(123)I]omazenil and SPECT.
Pinborg LH; Videbaek C; Hasselbalch SG; Sørensen SA; Wagner A; Paulson OB; Knudsen GM
J Neurol Neurosurg Psychiatry; 2001 May; 70(5):657-61. PubMed ID: 11309461
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous recovery of reduced cortical central benzodiazepine receptor binding potential on I-123 Iomazenil SPECT in a patient with status epilepticus.
Kuroda H; Ogasawara K; Aso K; Beppu T; Kobayashi M; Chida K; Ogawa A
Clin Nucl Med; 2010 Feb; 35(2):126-7. PubMed ID: 20090466
[No Abstract] [Full Text] [Related]
40. [A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 2)--Report on clinical usefulness in diagnosis of degenerative neurological diseases and mental disorders].
Torizuka K; Uemura K; Toru M; Shinohara Y; Nishimura T; Yonekura Y; Nakagawara J; Matsuda H; Sakai F; Matsuda K; Fukuyama H; Morimoto K
Kaku Igaku; 1996 Mar; 33(3):303-18. PubMed ID: 8622264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
